in this issue
Regions :: North America :: U.S.
Management-Led Group Raises Bid for MacDermid
January 10, 2007 | Chemical Week Editorial Staff
MacDermid says it has signed a definitive agreement to sell the company to a group led by chairman and CEO Daniel Leever and private equity firms Court Square Capital Partners (New York) and Weston Presidio (Boston, MA) in a deal valued at more than $1.3 billion, including the assumption or repayment of approximately $301 million of debt (CW, Sept. 6/13, 2006, p. 6). Under the agreement, stockholders will receive $35/share, an increase of $2.50/share, or 8%, over the initial offer announced in September, and a 21% premium to MacDermidâ€™s closing price of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee